The hypolipidemic effect of SU-13,437 in rats with natural endogenous hypertriglyceridemia.
D000284:Administration, Oral; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000032:analysis / Q000097:blood; D004906:Erythrocyte Count; D004987:Ethers / Q000627:therapeutic use; D005230:Fatty Acids, Nonesterified / Q000032:analysis / Q000097:blood; D005260:Female; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007958:Leukocyte Count; D008099:Liver / Q000032:analysis; D008112:Liver Glycogen / Q000032:analysis; D009281:Naphthalenes / Q000627:therapeutic use*; D009929:Organ Size; D010743:Phospholipids / Q000032:analysis / Q000097:blood; D011422:Propionates / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors; D014280:Triglycerides / Q000032:analysis / Q000097:blood*
D001786:Blood Glucose; D004987:Ethers; D005230:Fatty Acids, Nonesterified; D000960:Hypolipidemic Agents; D008112:Liver Glycogen; D009281:Naphthalenes; D010743:Phospholipids; D011422:Propionates; D014280:Triglycerides; D002784:Cholesterol